Search

NeoGenomics Inc

Open

BrancheGesundheitswesen

16.79 1.33

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

16.34

Max

17.07

Schlüsselkennzahlen

By Trading Economics

Einkommen

19M

2.2M

Verkäufe

15M

202M

EPS

-0.01

Gewinnspanne

1.11

Angestellte

2,500

EBITDA

19M

19M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+30.94% upside

Dividenden

By Acuity

Nächstes Ergebnis

28. Okt. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

370M

2.1B

Vorheriger Eröffnungskurs

15.46

Vorheriger Schlusskurs

16.79

NeoGenomics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

16. Okt. 2026, 20:02 UTC

Correlated Moves

Neogenomics Inc shares are declining amid a broader market trend, influenced by the sharply lower ARK Genomic Revolution ETF (ARKG) and negative news at Tempus AI.

15. Okt. 2026, 19:46 UTC

News

NeoGenomics expands partnership with Indica Labs to enhance digital pathology using AI-driven tools, aiming to streamline operations and improve diagnostic capabilities.

14. Okt. 2026, 20:21 UTC

Neogenomics Inc shares are trading lower in after-market hours, tracking significant declines in major U.S. stock indices amid rising inflation concerns and expectations of a rate hike.

13. Okt. 2026, 20:02 UTC

Neogenomics Inc is trading higher, having rebounded from earlier weakness, after reaching a notable peak around mid-afternoon on Tuesday.

8. Okt. 2026, 20:07 UTC

Neogenomics Inc shares are trading modestly higher, recovering from an early drop amid a broader market gain since Wednesday's close.

7. Okt. 2026, 20:07 UTC

Neogenomics Inc. shares fell sharply, closing well below the 20-day moving average amid overall market declines during Wednesday's trading session.

6. Okt. 2026, 23:31 UTC

Neogenomics Inc saw a notable increase in after-market trading, moving higher since Tuesday's close, despite being below its 20-day moving average.

5. Okt. 2026, 23:01 UTC

News

NeoGenomics shares declined in after-market trading following the announcement of a leadership transition and preliminary Q3 revenue expectations of approximately $209 million.

2. Okt. 2026, 20:07 UTC

Neogenomics Inc is advancing, reflecting a broader market trend with significant gains today, and is higher since Thursday's close.

1. Okt. 2026, 20:07 UTC

Neogenomics Inc shares fell sharply, closing at their lowest point of the day and marking five consecutive lower daily closes amid ongoing market weakness.

30. Sept. 2026, 20:31 UTC

Neogenomics Inc shares are higher in after-market trading, reversing four sessions of losses, following positive U.S. GDP growth and strong ADP employment data.

29. Sept. 2026, 20:07 UTC

Neogenomics Inc shares fell sharply, closing near their lowest point of the day after reversing from an early peak, amid ongoing challenges.

28. Sept. 2026, 23:11 UTC

Neogenomics Inc. saw a modest increase in after-market trading, reaching its highest cumulative return since Monday and remaining above its 20-day moving average.

25. Sept. 2026, 22:25 UTC

Neogenomics Inc shares declined in after-market hours following Friday's close, amid broader market weakness due to flat U.S. durable goods orders and low consumer sentiment.

24. Sept. 2026, 20:02 UTC

Neogenomics Inc is advancing sharply, maintaining a trend of higher daily closes since Wednesday, supported by strength in the broader health care services sector.

22. Sept. 2026, 20:07 UTC

News

Neogenomics Inc shares fell sharply, declining since Monday's close, despite early session gains and interest in its strategic shift towards precision oncology.

21. Sept. 2026, 21:21 UTC

Neogenomics Inc is trading modestly lower in after-market hours, declining from an initial high despite being above its 20-day moving average.

17. Sept. 2026, 20:07 UTC

Correlated Moves

Neogenomics Inc is advancing, supported by gains in the ARK Genomic Revolution ETF and positive broader market trends, marking five consecutive sessions of gains.

15. Sept. 2026, 20:07 UTC

Neogenomics Inc's shares are higher today, reflecting a notable increase since Monday's close. The stock remains above its 20-day moving average.

14. Sept. 2026, 23:46 UTC

Neogenomics Inc shares are modestly higher in after-market trading, maintaining a position above its 20-day moving average and near the top of its one-month range.

11. Sept. 2026, 21:01 UTC

Neogenomics Inc shares declined in after-market trading, coinciding with a significant drop in the Michigan Consumer Sentiment Index. No specific company news was identified.

10. Sept. 2026, 20:07 UTC

Neogenomics Inc shares are lower today amid a broader market decline and rising Treasury yields, with no specific company news identified.

9. Sept. 2026, 20:07 UTC

Neogenomics Inc's shares are higher Wednesday, despite an earlier pullback. No specific company news was identified to explain the price movement.

8. Sept. 2026, 19:26 UTC

Neogenomics Inc shares are higher today, continuing gains since Friday. The stock remains above its 20-day moving average and within its one-month range.

4. Sept. 2026, 23:20 UTC

Neogenomics Inc shares are higher in after-market trading, reflecting strong performance since Friday's close and positioning above its 20-day moving average.

2. Sept. 2026, 20:08 UTC

Neogenomics Inc is lower in Wednesday's session, continuing a trend of four consecutive declines. No specific news was identified to explain the move.

1. Sept. 2026, 20:08 UTC

Neogenomics Inc shares are lower today, continuing a downward trend since Monday. No specific company news was identified to explain the decline.

31. Aug. 2026, 20:07 UTC

Social Media

Neogenomics Inc shares are lower amid rising interest rate hike expectations following recent economic commentary. Earlier, the stock rebounded from a session high.

28. Aug. 2026, 20:51 UTC

Neogenomics Inc's shares are higher in after-market hours, moving significantly above their 20-day moving average and near the upper end of their one-month range.

27. Aug. 2026, 23:01 UTC

Neogenomics Inc. shares are higher in after-market trading, reflecting notable strength following Thursday's close. The stock remains above its 20-day moving average.

Peer-Vergleich

Kursveränderung

NeoGenomics Inc Prognose

Kursziel

By TipRanks

30.94% Vorteil

12-Monats-Prognose

Durchschnitt 21.5 USD  30.94%

Hoch 28 USD

Tief 19 USD

Basierend auf 8 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für NeoGenomics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

8 ratings

6

Buy

2

Halten

0

Sell

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
help-icon Live chat